Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in scientific reports, nature, adding:
“Excited to share this new work on a point-of-care SPR device for rapid detection of anti-PEG antibodies by Laura Pasquardini et al
PEGylation is widely used in biologic drugs, including extended half-life FVIII products for hemophilia A, to improve safety and efficacy.
However, PEG itself may trigger anti-PEG antibodies, potentially causing loss of treatment efficacy.
Our study presents a portable, low-cost platform capable of detecting anti-PEG IgG and IgM in just 15 minutes from human plasma, with nanomolar sensitivity and strong agreement with other methods (SPR and ELISA).
A step forward toward personalized monitoring of PEG immunogenicity and safer use of PEGylated therapies.”
Title: Development of a portable device for the detection of anti-PEG antibodies in human plasma
Authors: Laura Pasquardini, Nunzio Cennamo, Camilla Rossi, Roberto Canteri, Lia Vanzetti, Marten Beeg, Roberta Gualtierotti, Luca Pasquale Renzullo, Ines Tavoletta, Lucia Schiavone, Carla Valsecchi, Chiara Suffritti, Flora Peyvandi, Marco Gobbi, Luigi Zeni

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery